Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ludwig Enterprises Inc LUDG

Healthcare Biotechnology
Ludwig Enterprises is a publicly traded Medical Technology Holding Company with Precision Genomics, Inc. and MyRNA for Life, Inc. as wholly owned subsidiaries. Advancements in medical technology and Artificial Intelligence (AI) have awarded us with cutting-edge genomic tools, unheard-of even a generation ago. These genomic tools have the potential to not only detect diseases early but also to... see more

Recent & Breaking News (OTCPK:LUDG)

Ludwig Enterprises Launches Growth Plan

Accesswire February 14, 2023

Ludwig Enterprises, Inc. (OTC: LUDG) Prepares to Trade on the OTCQB Market

Accesswire January 12, 2023

Ludwig Enterprises Receives IRB Approval on Bladder Cancer Study

Accesswire January 3, 2023

Ludwig Enterprises Releases Annual 2022 Shareholder Letter

Accesswire December 21, 2022

Ludwig Enterprises Acquires Cutting-Edge Dietary Supplement Formula

Accesswire December 6, 2022

Ludwig Enterprises Announces Progress Towards Planned IPO (S1 Filing)

Accesswire November 17, 2022

Precision Genomics (a Ludwig Company) Revealed Major Medical News at a Sequire Spotlight Interview

Accesswire November 16, 2022

Precision Genomics Successfully Attends the LD Micro Conference

Accesswire November 7, 2022

Precision Genomics' New mRNA Technology May Be a Solution to Help Diagnose and Establish Treatment for Long Covid

Accesswire October 25, 2022

Precision Genomics (a Ludwig Company) Will Break Major Medical News at a Presentation for LD Micro Tuesday, Oct. 25th, 2022

Newsfile October 24, 2022

Ludwig's Genomic-Based mRNA Inflammatory Index - A Ground-Breaking Technology

Accesswire September 28, 2022

Ludwig Files a Patent That Could Be a Major Technology Breakthrough in Healthcare

Accesswire September 22, 2022

Ludwig Enterprises and Emerson Urology Associates Plan Bladder Cancer BCG Immunotherapy Study

Accesswire September 20, 2022

Ludwig Shareholder Letter: Our New Mission and Business Launch

Accesswire August 23, 2022

With a New CEO, Prestigious Medical Team, and New Business Direction, LUDG Paves the Way for a Potential Future IPO

Accesswire August 18, 2022

Ludwig Appoints Dr. Kyle Ambert Ph.D. to Scientific Advisory Board

Accesswire July 21, 2022

Ludwig Announces Engagement of Marvin S. Hausman MD as Chief Science Consultant

Accesswire July 19, 2022

Ludwig Enterprises Hires Anne Blackstone, CRNA as CEO and Director

Accesswire July 12, 2022

Ludwig Enterprises, Inc. Note Holders Waive Interest to Strengthen Company's Financial Position - The Company Continues A New Pathway Forward

Accesswire July 7, 2022

Ludwig Enterprises Sucessful 1st Round Funding -- New CEO -- New Division

Accesswire July 5, 2022